These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 14698262

  • 1. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in Glivec capsules.
    Ivanovic D, Medenica M, Jancic B, Malenovic A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Feb 05; 800(1-2):253-8. PubMed ID: 14698262
    [Abstract] [Full Text] [Related]

  • 2. Experimental design in reversed-phase high-performance liquid chromatographic analysis of imatinib mesylate and its impurity.
    Medenica M, Jancic B, Ivanovic D, Malenovic A.
    J Chromatogr A; 2004 Mar 26; 1031(1-2):243-8. PubMed ID: 15058589
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous determination of AMN107 and Imatinib (Gleevec, Glivec, STI571) in cultured tumour cells using an isocratic high-performance liquid chromatography procedure with UV detection.
    Guetens G, Prenen H, De Boeck G, van Oosterom A, Schöffski P, Highley M, de Bruijn EA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb 01; 846(1-2):341-5. PubMed ID: 16962394
    [Abstract] [Full Text] [Related]

  • 4. A validated LC method for imatinib mesylate.
    Vivekanand VV, Sreenivas Rao D, Vaidyanathan G, Sekhar NM, Avijit Kelkar S, Ramachandra Puranik P.
    J Pharm Biomed Anal; 2003 Dec 04; 33(5):879-89. PubMed ID: 14656579
    [Abstract] [Full Text] [Related]

  • 5. UV-spectrophotometric determination of imatinib mesylate and its application in solubility studies.
    Bende G, Kollipara S, Sekar V, Saha R.
    Pharmazie; 2008 Sep 04; 63(9):641-5. PubMed ID: 18819515
    [Abstract] [Full Text] [Related]

  • 6. Validation of a reversed-phase HPLC method for 1,10-phenanthroline-5,6-dione and analysis of its impurities by HPLC-MS.
    Shabir GA, Forrow NJ.
    J Pharm Biomed Anal; 2003 Sep 19; 33(2):219-30. PubMed ID: 12972087
    [Abstract] [Full Text] [Related]

  • 7. Stability-indicating HPTLC determination of imatinib mesylate in bulk drug and pharmaceutical dosage form.
    Vadera N, Subramanian G, Musmade P.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):722-6. PubMed ID: 16920319
    [Abstract] [Full Text] [Related]

  • 8. Stability-indicating UPLC method for determination of Imatinib Mesylate and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
    Nageswari A, Reddy KV, Mukkanti K.
    J Pharm Biomed Anal; 2012 Jul 17; 66():109-15. PubMed ID: 22502910
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous determination of nilotinib, imatinib and its main metabolite (CGP-74588) in human plasma by ultra-violet high performance liquid chromatography.
    Davies A, Hayes AK, Knight K, Watmough SJ, Pirmohamed M, Clark RE.
    Leuk Res; 2010 Jun 17; 34(6):702-7. PubMed ID: 20004471
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a HPLC-UV method for the determination in didanosine tablets.
    de Oliveira AM, Löwen TC, Cabral LM, dos Santos EM, Rodrigues CR, Castro HC, dos Santos TC.
    J Pharm Biomed Anal; 2005 Jul 15; 38(4):751-6. PubMed ID: 15967304
    [Abstract] [Full Text] [Related]

  • 11. Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
    Miura M, Takahashi N, Sawada K.
    J Chromatogr Sci; 2011 May 15; 49(5):412-5. PubMed ID: 21549035
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of impurities level of perindopril tert-butylamine in tablets.
    Medenica M, Ivanović D, Masković M, Jancić B, Malenović A.
    J Pharm Biomed Anal; 2007 Sep 03; 44(5):1087-94. PubMed ID: 17590561
    [Abstract] [Full Text] [Related]

  • 13. Validation of an HPLC method for determination of imatinib mesylate in rat serum and its application in a pharmacokinetic study.
    Bende G, Kollipara S, Movva S, Moorthy G, Saha R.
    J Chromatogr Sci; 2010 Sep 03; 48(5):334-41. PubMed ID: 20515524
    [Abstract] [Full Text] [Related]

  • 14. Development and validation of a column high-performance liquid chromatographic method for determination of sibutramine in capsules.
    Diefenbach IC, Friedrich M, Dos Santos MR, Bittencourt CF.
    J AOAC Int; 2009 Sep 03; 92(1):148-51. PubMed ID: 19382572
    [Abstract] [Full Text] [Related]

  • 15. Imatinib (Gleevec, Glivec) tumour tissue analysis by measurement of sediment and by liquid chromatography tandem mass spectrometry.
    Guetens G, Prenen H, De Boeck G, Highley M, de Wever I, van Oosterom AT, de Bruijn EA.
    J Sep Sci; 2006 Feb 03; 29(3):453-9. PubMed ID: 16544888
    [Abstract] [Full Text] [Related]

  • 16. Development and validation of a reversed-phase column liquid chromatographic method for the determination of five cephalosporins in pharmaceutical preparations.
    Elkady EF, Abbas SS.
    J AOAC Int; 2011 Feb 03; 94(5):1440-6. PubMed ID: 22165008
    [Abstract] [Full Text] [Related]

  • 17. Determination of zopiclone in tablets by HPLC and UV-spectrophotometry.
    Paw B, Misztal G.
    J Pharm Biomed Anal; 2000 Oct 03; 23(5):819-23. PubMed ID: 11022907
    [Abstract] [Full Text] [Related]

  • 18. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection.
    Tan KL, Ankathil R, Gan SH.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov 15; 879(30):3583-91. PubMed ID: 22000961
    [Abstract] [Full Text] [Related]

  • 19. Validation of a liquid chromatographic method for determination of tacrolimus in pharmaceutical dosage forms.
    Moyano MA, Simionato LD, Pizzorno MT, Segall AI.
    J AOAC Int; 2006 Nov 15; 89(6):1547-51. PubMed ID: 17225600
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.